Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment

NCT04667299 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Rabeprazole
DRUG: Bismuth potassium citrate
DRUG: Metronidazole
DRUG: Amoxicillin

Sponsor

Shanghai Zhongshan Hospital